Recombinant protein drugs are intimately associated with the impressive
success story of the Biotech Industry during the past thirty years, some
of them belonging to the most successful pharmaceutical products. More
than thirty different proteins are available for a variety of clinical
applications, over 300 proteins are presently being evaluated in
clinical trials.
In this new volume of the MDT series, historical, technical and clinical
aspects of recombinant protein drug discovery and development are
presented, covering past, present and future highlights. Leading
scientists and co-founders of early Biotech companies describe technical
breakthroughs and the fascinating story of pioneering discoveries, as
well as the long way of translating them into products and business.
Therefore, this book represents an exciting documentation of the
beginning of a new era in the pharmaceutical industry. In addition,
scientists from basic research, clinic and industry actively involved in
new developments discuss...